Use Of Thrombectomy Devices In Primary Percutaneous Interventions For ST-Elevation Myocardial Infarction - An Update

Journal
Article on Use Of Thrombectomy Devices In Primary Percutaneous Interventions For ST-Elevation Myocardial Infarction - An Update

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Overview

Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion modality in patients with ST-elevation myocardial infarction (STEMI). While PPCI is highly effective in achieving epicardial coronary reperfusion, a significant proportion of patients fail to achieve adequate myocardial reperfusion. This is in part due to the distal microembolisation of thrombus and plaque debris during PCI. Recognition of this has led to the development of a number of devices with different mechanisms of action that aim to reduce such distal embolisation and therefore improve end myocardial perfusion. Study results of thrombectomy devices however have been largely inconsistent, especially about clinical outcome data, and several meta-analyses have been carried out as a result. This review aims to critically analyse the literature data on thrombectomy during PPCI, taking into account the most recent studies and the latest metaanalyses looking to see whether thrombectomy use is associated with improved outcomes.

Featuring

Krishnaraj S Rathod - Department of Cardiology, Barts Health NHS Trust; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London; NIHR Cardiovascular Biomedical Research Unit, London Chest Hospital, London

Stephen M Hamshere - Department of Cardiology, Barts Health NHS Trust;  NIHR Cardiovascular Biomedical Research Unit, London Chest Hospital, London

Tawfiq R Choudhury - Department of Cardiology, Barts Health NHS Trust; NIHR Cardiovascular Biomedical Research Unit, London Chest Hospital, London

Daniel A Jones - Department of Cardiology, Barts Health NHS Trust;  Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London; NIHR Cardiovascular Biomedical Research Unit, London Chest Hospital, London

Anthony Mathur - Department of Cardiology, Barts Health NHS Trust; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London; NIHR Cardiovascular Biomedical Research Unit, London Chest Hospital, London

Loading Simple Education